SCHEMBL21403060

SCHEMBL21403060

NC(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2c(N2CCCCC2)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 12/20 0.55
CCND1 P24385 10/20 0.55
CCND3 P30281 5/20 0.51
CDK2 P24941 4/20 0.51
CDK6 Q00534 4/20 0.51
CCNA2 P20248 3/20 0.51
GAK O14976 1/20 0.51
CCNT1 O60563 1/20 0.51
FECH P22830 1/20 0.51
CDK9 P50750 1/20 0.51
CDK16 Q00536 1/20 0.51
MAP3K1 Q13233 1/20 0.51
CAMK2G Q13555 1/20 0.51
CAMK2D Q13557 1/20 0.51
Q6ZSR9 Q6ZSR9 1/20 0.51
PRKD2 Q9BZL6 1/20 0.51
SIK2 Q9H0K1 1/20 0.51
CDK1 P06493 1/20 0.51
CCND2 P30279 3/20 0.49
FGFR1 P11362 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29574744 0.92 CDK4 (0.55) CDK4CCND1CCND3CDK2CDK6
SCHEMBL20203470 0.92 CDK4 (0.55) CDK4CCND1CCND3CDK2CDK6
SCHEMBL21402870 0.91 CDK4 (0.55) CDK4CCND1CCND3CDK2CDK6
SCHEMBL21402797 0.90 CDK4 (0.53) CDK4CCND1CCND3CDK2CDK6
SCHEMBL28754847 0.90 CDK4 (0.53) CDK4CCND1CCND3CDK2CDK6
SCHEMBL29575302 0.90 CDK4 (0.53) CDK4CCND1CCND3CDK2CDK6
SCHEMBL29574826 0.90 CDK4 (0.53) CDK4CCND1CCND3CDK2CDK6
SCHEMBL20203545 0.89 CDK4 (0.61) CDK4CCND1CCND3CDK2CDK6
SCHEMBL29575585 0.84 CDK4 (0.53) CDK4CCND1CCND3CDK2CDK6
SCHEMBL21402843 0.82 CDK4 (0.51) CDK4CCND1CCND3CDK2CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110036012-B Pyrido [3,4-d ] pyrimidine derivatives and pharmaceutically acceptable salts thereof 帝人制药株式会社 2022-05-10 CN claimed
EP-3546458-B1 ((PYRIDIN-2-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE AND ((PYRIDAZIN-3-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES AS CDK4/6 INHIBITORS FOR TREATING E.G. RHEUMATOID ARTHRITIS, ARTERIOSCLEROSIS, PULMONARY FIBROSIS, CEREBRAL INFARCTION OR CANCER TEIJIN PHARMA LTD (JP) 2021-01-06 EP claimed
CN-110036012-B Pyrido [3,4-d ] pyrimidine derivatives and pharmaceutically acceptable salts thereof 帝人制药株式会社 2022-05-10 CN disclosed
EP-3546458-A1 PYRIDO[3, 4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2019-10-02 EP disclosed